
Any licensed influenza vaccine given as indicated for age and health status can be used to protect children against influenza in 2020/2021 season1
SEE 2020/21 AAP RECOMMENDATION
The disease-causing properties of the virus strains are modified to not cause influenza1
The virus strains replicate efficiently in the nasopharynx at 25°C, a temperature that is restrictive for replication of many wild-type influenza viruses1
The virus strains do not replicate at 37°C to 39°C, temperatures at which many wild-type influenza viruses grow efficiently1
FLUMIST QUADRIVALENT is a vaccine indicated for active immunization of persons 2-49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FLUMIST QUADRIVALENT is for intranasal administration only.
Please see full Prescribing Information for FLUMIST QUADRIVALENT, including Patient Information.
You may report side effects related to AstraZeneca products by clicking here.